SLC5A2 and type 2 diabetes mellitus: Finally, a recentmeta-analysis showed that SGLT2 inhibitors do not decrease PWV in patients withestablished cardiovascular disease or cardiovascular risk factors, but cause aslight and significant decrease in PWV in patients with T2DM [82].